15.23
Inmode Ltd stock is traded at $15.23, with a volume of 358.26K.
It is up +0.59% in the last 24 hours and down -0.33% over the past month.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
See More
Previous Close:
$15.14
Open:
$15.02
24h Volume:
358.26K
Relative Volume:
0.47
Market Cap:
$875.43M
Revenue:
$374.64M
Net Income/Loss:
$87.19M
P/E Ratio:
11.16
EPS:
1.365
Net Cash Flow:
$90.65M
1W Performance:
+0.13%
1M Performance:
-0.33%
6M Performance:
+6.50%
1Y Performance:
+7.10%
Inmode Ltd Stock (INMD) Company Profile
Compare INMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INMD
Inmode Ltd
|
15.23 | 870.26M | 374.64M | 87.19M | 90.65M | 1.365 |
|
ABT
Abbott Laboratories
|
110.91 | 189.86B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
347.21 | 133.54B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
90.76 | 116.07B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
51.42 | 74.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
93.05 | 53.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-28-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-17-24 | Initiated | BTIG Research | Buy |
| Jul-23-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-03-23 | Downgrade | UBS | Buy → Neutral |
| Oct-13-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-29-23 | Initiated | UBS | Buy |
| Feb-17-23 | Downgrade | Needham | Buy → Hold |
| Dec-21-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| May-18-21 | Initiated | Needham | Buy |
| Sep-03-19 | Initiated | Barclays | Overweight |
| Sep-03-19 | Initiated | Canaccord Genuity | Buy |
| Sep-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-03-19 | Initiated | UBS | Buy |
View All
Inmode Ltd Stock (INMD) Latest News
North Growth Management Ltd.'s InMode Ltd(INMD) Holding History - GuruFocus
(INMD) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Revenue per share of InMode Ltd. – HAM:154 - tradingview.com
Steadtrust LLC Boosts Position in InMode Ltd. $INMD - MarketBeat
Inmode Ltd (INMD) Stock News Today - TradingKey
Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK) - The Globe and Mail
InMode Ltd. (INMD) Stock Analysis: Evaluating Growth Potential in the Medical Device Sector - DirectorsTalk Interviews
InMode Ltd. (INMD) CEO holds 4,299,226 shares and extends proposal deadline - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages InMode Ltd. (INMD) Investors to Inquire about Securities Investigation - The National Law Review
InMode (INMD) Stock Margin Compression Deepens As Profitability Fades - Sahm
InMode reports stable Q2 2026 revenue at $95.6M, with a 13% rise in consumables sales and $501M cash reserves. - pluang.com
Needham Maintains InMode(INMD.US) With Hold Rating - Moomoo
InMode Ltd. (NASDAQ: INMD) CFO awarded 14,000 RSUs and reports holdings - Stock Titan
InMode (NASDAQ:INMD) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 - Morningstar
InMode Ltd. reports results for the quarter ended June 30Earnings Summary - tradingview.com
INMODE OUTLOOK FY ADJUSTED EPS USD 1.29-1.34 - Moomoo
Earnings Flash (INMD) InMode Ltd. Posts Q2 Adjusted EPS $0.35 per Share, vs. FactSet Est of $0.33 - marketscreener.com
Earnings Flash (INMD) InMode Ltd. Reports Q2 Revenue $95.6M, vs. FactSet Est of $93.1M - marketscreener.com
InMode: Q2 Earnings Snapshot - marketscreener.com
InMode Q2 2026 Earnings: Flat Revenue and Lower Margins - TradingKey
Earnings Flash (INMD) InMode Ltd. Reports Q2 Revenue $95.6M, Vs. FactSet Est of $93.1M - Moomoo
Tranche Update on InMode Ltd.'s Equity Buyback Plan announced on March 13, 2026. - marketscreener.com
Inmode Ltd (INMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
InMode Deadline Alert - TMX Newsfile
Earnings Preview: InMode to Report Financial Results Pre-market on August 05 - Moomoo
Form 4 InMode Ltd. For: 30 July By Investing.com - Investing.com Nigeria
Responsive Playbooks and the INMD Inflection - Stock Traders Daily
Renaissance Technologies LLC Acquires 149,800 Shares of InMode Ltd. $INMD - MarketBeat
Steel Partners urges InMode shareholders to vote against proposals By Investing.com - Investing.com South Africa
Steel Partners urges InMode shareholders to vote against proposals - Investing.com
INMD|Inmode Ltd|Price:15.490|Chg%:+0.320 - TradingKey
Inmode Ltd (INMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
InMode Ltd. $INMD Shares Bought by Steel Partners Holdings L.P. - MarketBeat
Inmode Ltd (INMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inmode Ltd (INMD) Balance Sheet - TradingKey
Inmode Ltd (INMD) Cash Flow - TradingKey
Inmode Ltd (INMD) Income Statement - TradingKey
Inmode Ltd (INMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inmode Ltd (INMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inmode Ltd (INMD) Institutional Confidence - TradingKey
Inmode Ltd (INMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
InMode Ltd. (INMD): Investor Outlook Highlights Strong Global Presence and Growth Potential - DirectorsTalk Interviews
Inmode Ltd (INMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
INMD|Inmode Ltd|Price:15.095|Chg%:-0.105 - TradingKey
InMode (INMD) board committee evaluates rival acquisition offers - Stock Titan
InMode Ltd. (INMD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
InMode stock trades around recent lows as revenue growth slows and Israel delisting plan adds uncert - Ad-hoc-news.de
ETFs Investing in InMode Ltd. Stocks - TradingView
InMode to Present at Upcoming Investor Conferences and Events - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages InMode Ltd. (INMD) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Inmode Ltd Stock (INMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):